Vorinostat Terminated Phase 2 Trials for Mantle Cell Lymphoma (MCL) / Follicular Lymphoma (FL) / Marginal Zone Lymphoma (MZL) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01500538A Pilot Study of Oral Vorinostat Plus Oral Eltrombopag Support in Patients With Lymphoma (VEIL)